Traders Buying Hemispherx (HEB) Shares as Ampligen Manufacturing Concerns Addressed
Tweet Send to a Friend
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are on the move once again today, adding another 12% onto yesterday's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
